IL2RA and type 1 diabetes mellitus: Most recently, clinical administration of CD4+CD25+CD127− T-cells has been shown to prolong remission of freshly diagnosed T1D [13] Here, we performed cross-sectional analysis of CD4+CD25+CD127− T-cells in long-lasting T1D.